Publications

Detailed Information

T1 및 T2 유방암의 유방보존수술 후에 동측 유방내 국소재발의 위험 요인 분석 : Factors Affecting the Ipsilateral Breast Tumor Recurrence after Breast Conserving Therapy in Patients with T1 and T2 Tumors

DC Field Value Language
dc.contributor.author김지훈-
dc.contributor.author한원식-
dc.contributor.author문형곤-
dc.contributor.author고은영-
dc.contributor.author이종원-
dc.contributor.author김은규-
dc.contributor.author박인애-
dc.contributor.author하성환-
dc.contributor.author지의규-
dc.contributor.author오승근-
dc.contributor.author윤여규-
dc.contributor.author김성원-
dc.contributor.author황기태-
dc.contributor.author노동영-
dc.date.accessioned2012-05-30T01:47:31Z-
dc.date.available2012-05-30T01:47:31Z-
dc.date.issued2009-12-
dc.identifier.citationJOURNAL OF BREAST CANCER; Vol.12 4; 324-330ko_KR
dc.identifier.issn1738-6756-
dc.identifier.urihttps://hdl.handle.net/10371/76605-
dc.description본 논문은 2008년 대한외과학회 추계학술대회에서 구연 발표되었음.ko_KR
dc.description.abstractPurpose: Nearly half of all breast cancers are treated with breast conserving therapy (BCT). The purpose of this study was to identify the risk factors for ipsilateral breast tumor recurrence (IBTR) after BCT in T1 and T2 breast cancer patients. Methods: The medical records of 294 T1 or T2 breast cancer patients who underwent BCT at Seoul National University Hospital between January 1998 and December 2002 were retrospectively reviewed. Kaplan-Meier curves and Cox proportional regression analysis were used to identify the significant clinicopathologic factors that influence IBTR. Results: Among the 294 patients, 12 patients (4.8%) developed IBTR after a median follow-up of 82 months. Univariate analysis demonstrated that younger age (<= 35 year) had significant associations with IBTR (p=0.006). Tumor size, lymph node status, histologic grade, extensive intraductal component, lymphovascular invasion, and close resection margins were not significant factor associated with IBTR. The triple negative breast cancer subtype also did not have significant association with IBTR. Multivariate analysis showed that the younger age at diagnosis was a significant predictor of IBTR with a FIR of 3.86 (p=0.036; 95% CI, 1.09-13.60). Conclusion: Younger age at diagnosis (<= 35) may be associated with an increased risk of IBTR in patients who underwent BCT.ko_KR
dc.language.isokoko_KR
dc.publisherKOREAN BREAST CANCER SOCko_KR
dc.subjectAge factorsko_KR
dc.subjectLocal neoplasm recurrenceko_KR
dc.subjectBreast conserving therapyko_KR
dc.subjectBreast neoplasmsko_KR
dc.subject젊은연령ko_KR
dc.subject유방암ko_KR
dc.subject유방보존수술ko_KR
dc.subject국소재발ko_KR
dc.titleT1 및 T2 유방암의 유방보존수술 후에 동측 유방내 국소재발의 위험 요인 분석ko_KR
dc.title.alternativeFactors Affecting the Ipsilateral Breast Tumor Recurrence after Breast Conserving Therapy in Patients with T1 and T2 Tumorsko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthorKim, Ji Hoon-
dc.contributor.AlternativeAuthorHan, Wonshik-
dc.contributor.AlternativeAuthorMoon, Hyeong-Gon-
dc.contributor.AlternativeAuthorKo, Eunyoung-
dc.contributor.AlternativeAuthorLee, Jong Won-
dc.contributor.AlternativeAuthorKim, Eun-Kyu-
dc.contributor.AlternativeAuthorPark, In-Ae-
dc.contributor.AlternativeAuthorHa, Sung Whan-
dc.contributor.AlternativeAuthorChie, Eui Kyu-
dc.contributor.AlternativeAuthorOh, Seung Keun-
dc.contributor.AlternativeAuthorYoun, Yeo-Kyu-
dc.contributor.AlternativeAuthorKim, Sung-Won-
dc.contributor.AlternativeAuthorHwang, Ki-Tae-
dc.contributor.AlternativeAuthorNoh, Dong-Young-
dc.identifier.doi10.4048/jbc.2009.12.4.324-
dc.citation.journaltitleJOURNAL OF BREAST CANCER-
dc.description.citedreferenceHan W, 2010, BREAST CANCER RES TR, V119, P193, DOI 10.1007/s10549-009-0388-z-
dc.description.citedreferenceBenson JR, 2009, LANCET, V373, P1463-
dc.description.citedreferenceLuini A, 2009, BREAST CANCER RES TR, V113, P397, DOI 10.1007/s10549-008-9929-0-
dc.description.citedreferenceNguyen PL, 2008, J CLIN ONCOL, V26, P2373, DOI 10.1200/JCO.2007.14.4287-
dc.description.citedreferenceLee JW, 2007, J BREAST CANCER, V10, P206-
dc.description.citedreferenceDent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045-
dc.description.citedreferenceKANG SH, 2007, J KOREAN SURG SOC, V73, P385-
dc.description.citedreferenceHaffty BG, 2006, J CLIN ONCOL, V24, P5652, DOI 10.1200/JCO.2006.06.5664-
dc.description.citedreferenceAhn SH, 2006, BREAST CANCER RES TR, V99, P209, DOI 10.1007/s10549-006-9188-x-
dc.description.citedreferenceWapnir IL, 2006, J CLIN ONCOL, V24, P2028, DOI 10.1200/JCO.2005.04.3273-
dc.description.citedreferenceKomoike Y, 2006, CANCER, V106, P35, DOI 10.1002/cncr.21551-
dc.description.citedreferenceAbe O, 2005, LANCET, V366, P2087-
dc.description.citedreferenceNoh WC, 2005, WORLD J SURG, V29, P1001, DOI 10.1007/s00268-005-7928-4-
dc.description.citedreferenceKim KJ, 2005, JPN J CLIN ONCOL, V35, P126, DOI 10.1093/jjcolyhi039-
dc.description.citedreferenceHan WS, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-82-
dc.description.citedreferenceMORROW M, 2004, DIS BREAST, P719-
dc.description.citedreferenceArriagada R, 2003, ANN ONCOL, V14, P1617, DOI 10.1093/annonc/mdg452-
dc.description.citedreferenceSingletary SE, 2002, AM J SURG, V184, P383-
dc.description.citedreferenceVeronesi U, 2002, NEW ENGL J MED, V347, P1227-
dc.description.citedreferenceFisher B, 2002, NEW ENGL J MED, V347, P1233-
dc.description.citedreferenceFreedman GM, 2002, J CLIN ONCOL, V20, P4015, DOI 10.1200/JCO.2002.03.155-
dc.description.citedreferenceHaffty BG, 2002, LANCET, V359, P1471-
dc.description.citedreferenceJobsen JJ, 2001, EUR J CANCER, V37, P1820-
dc.description.citedreferenceSasson AR, 2001, CANCER, V91, P1862-
dc.description.citedreferenceVoogd AC, 2001, J CLIN ONCOL, V19, P1688-
dc.description.citedreferencePark CC, 2000, J CLIN ONCOL, V18, P1668-
dc.description.citedreferenceFreedman G, 1999, INT J RADIAT ONCOL, V44, P1005-
dc.description.citedreferencePeterson ME, 1999, INT J RADIAT ONCOL, V43, P1029-
dc.description.citedreferenceSUH CO, 1997, J KOREAN SOC THER RA, V15, P331-
dc.description.citedreferenceBORGER J, 1994, J CLIN ONCOL, V12, P653-
dc.description.citedreferenceWAZER DE, 1992, J CLIN ONCOL, V10, P356-
dc.description.citedreferenceSOLIN LJ, 1991, INT J RADIAT ONCOL, V21, P279-
dc.description.citedreferenceJACQUEMIER J, 1990, BRIT J CANCER, V61, P873-
dc.description.citedreferenceVERONESI U, 1990, EUR J CANCER, V26, P671-
dc.description.citedreferenceFOURQUET A, 1989, INT J RADIAT ONCOL, V17, P719-
dc.description.citedreferenceLOCKER AP, 1989, BRIT J SURG, V76, P890-
dc.description.tc1-
Appears in Collections:
Files in This Item:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share